Evolent Health issues $166.75M of 4.50% convertible notes, repurchases existing notes and stock

Evolent Health, Inc.

Issued $166.75M aggregate principal of 4.50% convertible senior notes due 2031 at 100% par.
Used net proceeds of $161.2M plus liquidity to repurchase $167.4M of 1.50% convertible notes due 2025 for $167.6M.
Concurrently repurchased $40M of Class A common stock in privately negotiated transactions.
Initial conversion price of ~$13.53 per share, representing a 50% premium over August 18 closing price.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.